Tumour-derived Factors Which Induce Endothelial Tissue Factor and Enhance the Procoagulant Response to TNF

By Murray J.C.   Clauss M.   Thurston G.   Stern D.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 273-277

Informa Healthcare

Access to resources Recommend Favorite

The `peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity

By Graner Michael W.  

International Journal of Hyperthermia, Vol. 29, Iss. 5, 2013-08 ,pp. : 380-389

Informa Healthcare

Access to resources Recommend Favorite

Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine

By Epple Laura M.  

International Journal of Hyperthermia, Vol. 29, Iss. 5, 2013-08 ,pp. : 390-398

Informa Healthcare

Access to resources Recommend Favorite

Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells

By Alessandri Giulio   Chirivi Renato   Fiorentini Simona   Dossi Romina   Bonardelli Stefano   Giulini Stefano   Zanetta Gerardo   Landoni Fabio   Graziotti Pier   Turano Adolfo   Caruso Arnoldo   Zardi Luciano   Giavazzi Raffaella   Bani Maria  

Clinical and Experimental Metastasis, Vol. 17, Iss. 8, 1999-10 ,pp. : 655-662

Springer Publishing Company

Access to resources Recommend Favorite

Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes

By Baj-Krzyworzeka Monika   Szatanek Rafał   Węglarczyk Kazimierz   Baran Jarosław   Urbanowicz Barbara   Brański Piotr   Ratajczak Mariusz   Zembala Marek  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 808-818

Springer Publishing Company

Access to resources Recommend Favorite